The same APT hammered critical bugs in Citrix NetScaler (CVE-2025-5777) and the Cisco Identity Service Engine (CVE-2025-20337) in a sign of growing adversary interest in identity and access management systems.
Novartis says Phase 3 data prove new antimalarial could address resistance
Novartis’ experimental malaria treatment passed a Phase 3 trial, bringing it one step closer to becoming the newest tool in an aging arsenal of antimalarials. The drug, called GanLum, was non-inferior to Novartis’ standard-of-care treatment …
FDA announces new regulatory pathway for personalized rare disease therapies
Top FDA officials on Wednesday sketched out a new regulatory approach that aims to keep pace with scientific advances in personalized medicine. It builds off the celebrated case of Baby KJ, who was treated with …
Google Looks to Dim ‘Lighthouse’ Phishing-as-a-Service Op
The phishing kit, run by a group known as the “Smishing Triad,” has powered massive amounts of unpaid tolls and package tracking texts.
Pazdur vs. Prasad: Can the CDER-CBER dynamic change under new leadership?
FDA Commissioner Marty Makary spent hours over the weekend at Rick Pazdur’s house trying to convince the agency’s longtime cancer chief to step up to the role of top drug regulator, a source familiar with …
Lilly drops CVS as drug benefits manager — report
Eli Lilly has dropped CVS Health as its pharmacy benefit manager, selecting Rightway instead, according to a report from Bloomberg News. The outlet reported that at the beginning of the new …
Chinese biotechs are shedding their fast-follower reputations as innovation surges
LONDON — China’s biotech sector is steadily moving beyond a “me-too” approach to drug development thanks to a surge in quality talent, regulatory flexibility and a level of speed that’s tough to rival, industry executives said …
WuXi AppTec plants ‘flag down’ in Europe with new Munich headquarters
LONDON — WuXi AppTec is creating its first European headquarters at its existing facility in Germany, the company’s US and EU president Rick Connell said Wednesday. “The time is right now to put the flag …
Microsoft Exchange ‘Under Imminent Threat’, Act Now
Threats against Microsoft Exchange continue to mount, but there are steps both organizations and Microsoft can take.
Immatics shares early bispecific data as it seeks to make its name beyond cell therapy
Immatics is planning to advance two T cell receptor-based bispecific antibodies based on results reported Wednesday across Phase 1 trials. The company’s bispecific work previously faced questions when Bristol Myers Squibb …
Alkermes reports messy Phase 2 narcolepsy data, stock drops
Alkermes’ quest to develop a new narcolepsy drug became murkier on Wednesday following another Phase 2 readout. The company claimed success, noting the 18 mg high dose achieved a statistically significant …
Phishing Tool Uses Smart Redirects to Bypass Detection
A campaign against Microsoft 365 users leverages Quantum Route Redirection, which simplifies previously technical attack steps and has affected victims across 90 countries.